Authors:Luigi Di Biase, MD, PhD, FHRS, FACCEdward P Walsh, MDSection Editor:Brian Olshansky,

MDDeputy Editor:Gordon M Saperia, MD

Contributor Disclosures

All topics are updated as new evidence becomes available and our peer review process is complete.

Literature review current through: Sep 2020. | This topic last updated: Jun 10, 2020.

INTRODUCTION

The term preexcitation was originally used in the first half of the 20 th century to describe premature
activation of the ventricles in patients with the Wolff-Parkinson-White (WPW) syndrome [1]. This term
has since been broadened to include other less common conditions in which antegrade ventricular
activation occurs partially or totally via an abnormal conduction pathway. This topic will discuss the
anatomy, clinical manifestations, diagnosis, and treatment of patients with atriofascicular (“Mahaim”)
pathway tachycardias. Additional details regarding WPW syndrome and other syndromes with accessory
conductions pathways are presented separately. (See “General principles of asynchronous activation
and preexcitation” and “Wolff-Parkinson-White syndrome: Anatomy, epidemiology, clinical
manifestations, and diagnosis” and “Treatment of symptomatic arrhythmias associated with the Wolff-
Parkinson-White syndrome” and “Lown-Ganong-Levine syndrome and enhanced atrioventricular nodal
conduction”.)

NOMENCLATURE, ANATOMY, AND PHYSIOLOGY

Nomenclature and anatomy — Several types of abnormal conduction pathways have been identified
(figure 1), although firm histopathologic correlation with clinical arrhythmias has not been established
for all [2].

●Accessory atrioventricular (AV) pathways — Classic Wolff-Parkinson-White (WPW) syndrome is caused

by a small band of myocytes running between atrial and ventricular muscle that bridges the normal
fibrous insulation along the AV junction, resulting in a pattern of short PR interval and a delta wave on
the electrocardiogram (ECG). These connections, formerly referred to as bundles of Kent, are now
designated by the more accurate label of “accessory AV pathways” [3]. (See “Wolff-Parkinson-White
syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis”.)

●Accessory atrio-Hisian pathways — Accessory atrio-Hisian pathways (also referred to as James fibers)
have been implicated as the potential cause of the Lown-Ganong-Levine syndrome. In the initial report
(authored by James) of these pathways, a potential microscopic conduction fiber pathway was seen
linking atrial myocardium directly to the bundle of His, thereby bypassing the AV node and resulting in
an ECG appearance of a short PR interval, but with a normal QRS and no delta wave [4]. What remains
uncertain, however, is whether this is a true clinical entity or simply conventional AV nodal reentry in a
patient who happens to have enhanced conduction in their AV nodal fast pathway. (See “Lown-Ganong-
Levine syndrome and enhanced atrioventricular nodal conduction”.)

●Atriofascicular pathways — Atriofascicular tachycardia is now understood to involve a specialized

conduction pathway arising from the lateral right atrium that extends far down into the body of the
right ventricle (RV) and is quite distinct from the AV node and bundle of His. Although nodoventricular
fibers might still be involved in some rare cases of atypical supraventricular tachycardia [5-7],
atriofascicular tachycardia is now known to be caused by a reentry circuit that is critically dependent on
an atriofascicular pathway or a long AV fiber with unique conduction properties. The term “Mahaim”
fiber is still retained by some as a shorthand synonym for an atriofascicular pathway, although it is
universally understood that the label is imprecise.

Clarification of the true mechanism for atriofascicular pathway tachycardia came about in the 1980s as a
result of careful intracardiac electrophysiologic studies and fortuitous observations during arrhythmia
surgery. Initial observations suggested the possibility of an unusual type of pathway along the right AV
groove possessing decremental conduction properties [8]. These observations were further supported
by the elimination of presumptive “Mahaim” fiber tachycardia; this was done by surgically interrupting
atriofascicular pathways in two patients along the anterolateral tricuspid valve, proving that the culprit
conduction pathway was truly remote from the AV node [9].

Electrophysiology — Atriofascicular pathways exhibit structural and functional features that can almost
be likened to a secondary AV conduction system. The atrial end is comprised of cells with AV nodal-like
properties situated along the right AV groove in the lateral or anterolateral position. Conduction at the
atrial end exhibits clear decrement in response to premature beats, and a Wenckebach-type of
periodicity in response to trains of rapid atrial pacing, very similar to behavior of the normal AV node.
There is even histologic evidence of cells resembling AV nodal tissue at this site [10].

Traveling away from the atrial end is a long fiber that crosses the AV groove and descends into the body
of the RV along the endocardium of the anterior free wall. The fiber is electrically insulated along its
length similar to the His bundle or bundle branches, such that the site of earliest ventricular activation is
not at the AV groove as seen with conventional accessory AV pathways in WPW syndrome, but much
further towards the apex of the RV in the region where the moderator band attaches to the free wall.
Because a major extension of the normal right bundle branch also runs along the moderator band
towards the free wall, the terminal portion of an atriofascicular pathway is closely approximated or even
attached to normal conduction tissues.

Conceptually, one can envision three potential models for the terminal portion of an atriofascicular fiber
[11-13]:
●Termination far down on the RV free wall but not attached to the right bundle branch (which would
most accurately be described as a “long AV fiber”) [14].

●Termination within the muscle of the moderator band, close to, but not in direct contact with, the
distal right bundle branch (intermediate between “AV” and “atriofascicular”).

●Fused in direct electrical continuity with the distal right bundle branch (true “atriofascicular”).

All three models can account for the clinical behavior of this particular pathway, but based on detailed
analysis of conduction patterns during electrophysiologic testing [15], the vast majority of cases seem to
involve the fusion model of direct continuity. Occasionally, cases are reported with subtle
electrophysiologic findings that suggest a long fiber with decremental conduction that does not quite
make contact with right bundle tissue [16], but the distinction is usually not critical from a treatment
point of view, nor is it always easy to make the distinction. Hence, the label “atriofascicular” is applied
unless there is very convincing evidence to the contrary.

CLINICAL FEATURES

Many patients with atriofascicular pathways have minimal electrocardiogram (ECG) changes in sinus
rhythm, though a subtle delta wave with a normal PR interval may be seen in some cases. Patients
typically have a structurally and functionally normal heart and do not come to medical attention until
they experience a tachycardia event. The lone exception is patients with Ebstein’s anomaly of the
tricuspid valve, a situation which is strongly associated with atriofascicular pathways (as well as WPW
syndrome) [17,18]. (See “Clinical manifestations and diagnosis of Ebstein anomaly” and “Wolff-
Parkinson-White syndrome: Anatomy, epidemiology, clinical manifestations, and diagnosis”, section on
‘Anatomy’.)

Arrhythmias and symptoms — Antidromic reentry (antegrade conduction over the accessory pathway
with retrograde conduction via the AV node) is the most common tachycardia seen with atriofascicular
pathways (waveform 1). Less frequently, the retrograde limb involves a second conventional accessory
AV pathway, or retrograde conduction may shift between the AV node and one of these secondary
accessory AV pathways [13,17,19,20]. Other tachycardia substrates often coexist with an atriofascicular
fiber. Approximately 40 percent of patients with a proven atriofascicular fiber have other accessory AV
pathways and/or dual AV nodal physiology [17,19,21-23]. Often, a conventional Wolff-Parkinson-White
pathway can mask the presence of an atriofascicular pathway, which only becomes apparent after
surgical or catheter ablation of the primary accessory pathway [21]. Atriofascicular pathways can also
function as a bystander and conduct anterograde impulses during AV nodal reentrant tachycardia, atrial
flutter, or any other sort of atrial tachycardia (figure 2) [19,22].
The two most distinctive functional characteristics of an atriofascicular pathway include its decremental
properties and the fact that it is only capable of antegrade conduction [24]. Therefore, when actively
involved as part of a reentrant tachycardia, it will only support antidromic reentry. Passive antegrade
conduction may also occur over an atriofascicular pathway during sinus rhythm or any other type of
supraventricular tachycardia.

Some atriofascicular pathways are known to exhibit intrinsic automaticity, which can present as single
premature beats or brief salvos that appear to be of ventricular origin [25,26].

ECG findings

Resting ECG — The resting ECG in patients with an atriofascicular fiber is often normal [17,19,21,24].
This is due to preferential ventricular activation via the AV node at normal resting heart rates. There are
several conditions under which conduction via the atriofascicular pathway occurs:

●Enhanced vagal tone, rapid pacing, or a premature beat may slow AV nodal conduction and favor
conduction partially or exclusively over the atriofascicular pathway [17].

●The relative refractoriness of the AV node and fiber may change with time, resulting in a variable
degree of preexcitation during sinus rhythm.

●Premature atrial complexes (PAC; also referred to a premature atrial beat, premature supraventricular
complex, or premature supraventricular beat) or an ectopic rhythm arising near the atrial insertion can
preferentially engage the atriofascicular pathway.

Whenever some or all conduction proceeds over an atriofascicular pathway, the PR interval still falls into
the normal range, but the QRS is variably distorted by early RV activation, resulting in a pattern of partial
or complete left bundle branch block. The absence of a sharp septal Q wave due to relative delay in left
bundle activation results in a somewhat slurred QRS upstroke, but whether the initial portion of the QRS
should be referred to as a true delta wave is a matter of semantics. Regardless, conduction over an
atriofascicular pathway does indeed satisfy the strict definition of preexcitation in that a ventricular site
is activated ahead of the normal His-Purkinje system.
One study of sinus rhythm ECGs of patients with atriofascicular pathways identified a narrow QRS
complex with an rS pattern in lead III in 20 of 33 cases (61 percent) [16]. In contrast, among 200 young
adults with a history of palpitations but no structural heart disease, a narrow QRS with an rS in III was
found in only 6 percent. More recently, terminal notching and slurring in the non-preexcited QRS has
been described as a common finding in patients with atriofascicular pathways that resolves once the
involved fibers are successfully eliminated with catheter ablation [27].

ECG with antidromic reentrant tachycardia — Antidromic reentry involving an atriofascicular pathway
has a regular rate and abrupt onset. Several ECG features that have been suggested as characteristic of
antidromic reentry involving an atriofascicular pathway include (waveform 1) [21,28]:

●QRS axis between 0 and minus 75º

●QRS duration of 0.15 seconds or less

●R-wave in lead 1

●rS complex in lead V1

●Precordial transition in lead V4 or later

●Cycle length between 220 and 450 milliseconds (heart rates of 130 to 270)

Although these surface ECG markers can be a useful starting point in the acute setting to raise suspicion
about an atriofascicular mechanism, they are not diagnostic, and invasive electrophysiology studies are
usually required for an accurate diagnosis. (See ‘Evaluation’ below.)

EVALUATION

Patients with suspected atriofascicular (“Mahaim” fiber) tachycardia should all have had an ECG as part
of the initial presentation. Additional testing for such patients also typically includes:

●Transthoracic echocardiography to assess for any structural cardiac abnormalities (especially Ebstein’s
anomaly).
●Invasive electrophysiology studies (EPS) for confirmation of the diagnosis and, in many cases,
therapeutic catheter ablation of the abnormal pathway.

When invasive EPS is performed, baseline sinus rhythm intervals are often normal or show only slightly
shortened HV intervals (waveform 2). Atrial pacing maneuvers should uncover the antegrade conduction
abnormalities [29]. The AH interval and the A-V time will prolong in the expected fashion as
progressively premature atrial extrastimuli are delivered, but at some point there will be a shift (often
subtle at first) in antegrade conduction away from the AV node and towards the atriofascicular pathway.
This manifests itself as a progressively shortened HV interval and a more preexcited-appearing QRS with
left bundle branch block features and earliest ventricular timing towards the RV apical region.

Coaxing conduction antegrade down the atriofascicular pathway can be highly dependent on the site of
atrial stimulation. The closer the stimulation site is to the atrial end of the fiber, the more obvious and
dramatic the preexcitation. Thus, atrial stimulation from the right atrial appendage or lateral right
atrium along the AV groove is the preferred technique for uncovering these fibers. Stimulation from the
coronary sinus or some other left atrial site will often fail completely to engage an atriofascicular
pathway since the AV node has a chance to conduct long before the atrial activation wavefront ever
reaches the right lateral region.

As atrial extrastimuli are delivered more prematurely, conduction begins to approach maximal
preexcitation where the His signal becomes obscured by the preexcited QRS. Even at this point, the A-
QRS interval may continue to prolong because of decremental conduction within the pathway.
Eventually, a critical coupling interval can be reached where the normal AV node is refractory and
antegrade conduction occurs exclusively over the atriofascicular pathway. This is the point at which
antidromic reentry can develop, since conduction may now return to the atrium in a retrograde fashion
via the His bundle and AV node to complete the circuit. Tachycardia can also be induced with rapid atrial
pacing that achieves the same critical shift towards exclusive antegrade conduction in the atriofascicular
pathway.

During induced antidromic tachycardia involving an atriofascicular pathway, the QRS will have a pattern
of complete left bundle branch block with no preceding His bundle potential. Instead, the His potential
will be observed after the QRS, and on close inspection of the His bundle electrogram, the His-Purkinje
system can usually be confirmed to be activated in a retrograde manner from distal-to-proximal as
opposed to the normal proximal-to-distal pattern seen in sinus rhythm [29,30]. When the RV is mapped
carefully, the earliest ventricular activation will be localized to the anterior free wall near the insertion
of the moderator band [31]. Unless another retrograde AV bypass tract or a retrograde AV nodal slow-
pathway is present, earliest retrograde atrial timing during antidromic tachycardia will usually be
recorded on the His bundle catheter. Premature atrial extrastimuli delivered during preexcited
tachycardia not altering the atrial activation at the septal level, but resulting in advancement of the next
ventricular and atrial complexes (ie, tachycardia reset) definitely indicate that the atriofascicular
pathway is an integral part of the reentrant circuit (ie, the tachycardia is sustained by antidromic
reentry) [30,32].

DIAGNOSIS

In some instances, the presence of an atriofascicular pathway may be suspected based on the surface
ECG, on which the PR interval remains normal but the QRS is variably distorted by early RV activation,
resulting in a pattern of partial or complete left bundle branch block. However, given that the ECG
findings may be subtle or entirely absent at rest, intracardiac electrophysiologic study is usually required
to make a firm diagnosis of an atriofascicular pathway. Baseline sinus rhythm intervals can be normal or
may show a slightly short HV interval with RV activation occurring a bit earlier than expected. However,
when atrial pacing maneuvers are performed, the antegrade conduction abnormalities become more
apparent [29]. (See ‘Evaluation’ above.)

TREATMENT

Acute management — In the acute setting at initial presentation of sustained antidromic tachycardia
involving an atriofascicular pathway, the wide-QRS pattern on ECG may be hard to distinguish from
several other tachycardia mechanisms, including ventricular tachycardia. It is therefore best to approach
acute treatment according to the standard algorithm for any wide-QRS complex tachycardia. (See “Wide
QRS complex tachycardias: Approach to management”.)

For patients with a known established diagnosis of atriofascicular pathway tachycardia (ie, a
supraventricular tachycardia [SVT] rather than ventricular tachycardia or wide-QRS complex tachycardia
of unknown origin), the approach to acute therapy is similar to other SVTs. Since antidromic
atriofascicular reentry is regular and monomorphic, this means that a cautious trial of adenosine is a
reasonable first step if the patient is hemodynamically stable. Adenosine is nearly always effective in
this setting. (See “Overview of the acute management of tachyarrhythmias”, section on ‘Narrow QRS
complex tachyarrhythmias’.)

Chronic management — For chronic treatment of atriofascicular pathway tachycardia, most patients are
suitable candidates for catheter ablation, but the techniques used for mapping differ somewhat from
those used for a conventional Wolff-Parkinson-White pathway. In rare circumstances, pharmacologic
therapy can be used in an effort to suppress arrhythmias.
Catheter ablation — The atrial end of the atriofascicular pathway is the most productive and reliable site
for ablation [29,33], but because atriofascicular pathways are capable only of antegrade conduction, the
atrial insertion cannot be easily mapped with simple analysis of retrograde atrial activation patterns.
Instead, electrophysiologists must rely on one or more of the following techniques:

●Stimulus to “delta-wave” mapping (aimed to disclose the atrial pacing site along the tricuspid annulus
associated with the shortest “stimulus-to-delta” interval) [33].

●Premature right atrial stimulation during antidromic tachycardia (to identify the site from which the
latest coupled atrial extrastimulus advances the next ventricular electrogram) [30].

●Direct recording of a discrete potential from the fiber near the tricuspid annulus [29,31,34].

Identification of a site with a discrete potential has become the most widely used and dependable
technique for mapping atriofascicular fibers (waveform 2). Promising sites will register a sharp signal
that is very similar in frequency and amplitude to a His bundle potential, with timing midway between
the atrial and ventricular electrograms during antidromic tachycardia or preexcited atrial pacing
[29,31,34-37]. These potentials can be recorded on the atrial side of the tricuspid valve at the AV
groove, as well as on the ventricular side just below the valve. The combination of its long ventricular
endocardial course, arborization of its distal segments, and potential fusion with the right bundle
branch, all make identification of the true ventricular insertion of these fibers difficult [31]. Fortunately,
precise location of the ventricular end is usually not critical since ablation is never performed at this site.

Once thorough mapping has been performed and a high-quality atriofascicular potential has been
localized, radiofrequency (RF) ablation can be performed using standard techniques. A brief period of
accelerated automaticity from the atriofascicular fiber often occurs as the tissue is heated (similar to
ablation near the normal AV node and His bundle) and is usually a promising sign. This automaticity
should resolve within the first few seconds of the RF application if the catheter tip is in good position.
The reported permanent success rate for RF ablation in this condition is excellent, in the range of 87 to
100 percent [29,38].

Pharmacologic therapy — Pharmacologic therapy can be used as an alternative to catheter ablation if

necessary. Prior to the development of ablation techniques, empiric drug therapy was the preferred
treatment of “Mahaim” fiber tachycardia. Since this is a relatively rare condition, there have been no
large-scale comparative trials of different classes of drugs. The published data are limited to case reports
and small studies demonstrating sensitivity to various classes of antiarrhythmic agents. Because drug
therapy is so uncommonly used (and studied) in this condition, and since for most patients catheter
ablation is by far the preferred option, it is not possible to make a recommendation for any one agent.
Antegrade conduction in atriofascicular pathways appears to be acutely sensitive to adenosine but not
necessarily to other agents that predominately affect the AV node, such as calcium blockers and beta
blockers [39]. In some cases, however, the AV nodal blocking agents may be effective in preventing
tachycardia by affecting AV nodal conduction in the retrograde limb of the tachycardia. Both class IA and
IC agents, as well as class III agents, also may slow or prevent tachycardia in patients with antidromic
tachycardia related to atriofascicular pathways [40].

SUMMARY AND RECOMMENDATIONS

●Cardiac preexcitation describes premature activation of the ventricles over an abnormal pathway
distinct from the normal cardiac conduction system. (See ‘Nomenclature, anatomy, and physiology’
above.)

•The classic form of cardiac preexcitation occurs in Wolff-Parkinson-White (WPW) syndrome, involving a
short connection along the atrioventricular (AV) groove, referred to as an “accessory AV pathway.”

•Atriofascicular pathways, formerly referred to as “Mahaim” fibers, are now understood to involve a
specialized conduction pathway arising from the lateral right atrium that extends far down into the body
of the right ventricle and is quite distinct from the AV node and bundle of His.

●Atriofascicular pathways exhibit structural and functional features that can almost be likened to a
secondary AV conduction system. (See ‘Electrophysiology’ above.)

●Many patients with atriofascicular pathways have minimal electrocardiogram (ECG) changes, but in
some cases a subtle delta wave with a normal PR interval can be seen. The most common tachycardia in
this condition is antidromic reentry using the atriofascicular pathway as the antegrade limb and the AV
node as the retrograde limb (See ‘Clinical features’ above.)

●Patients with suspected atriofascicular (“Mahaim” fiber) tachycardia should all have had an ECG as part
of the initial presentation. Additional testing for such patients also includes transthoracic
echocardiography and, frequently, invasive electrophysiology studies for confirmation of the diagnosis
and, in many cases, therapeutic catheter ablation of the abnormal pathway. (See ‘Evaluation’ above and
‘Diagnosis’ above.)
●Most patients are suitable candidates for transcatheter ablation, but the techniques used for mapping
differ somewhat from those used for a conventional WPW pathway. In rare circumstances,
pharmacologic therapy can be used in an effort to suppress arrhythmias. (See ‘Treatment’ above.)

REFERENCES

Ohnell, RF. Pre-Excitation: A Cardiac Abnormality, Norstedt and Soner, Stockholm 1944.

Hoffmayer KS, Han FT, Singh D, Scheinman MM. Variants of accessory pathways. Pacing Clin
Electrophysiol 2020; 43:21.

Anderson RH, Becker AE, Brechenmacher C, et al. Ventricular preexcitation. A proposed nomenclature
for its substrates. Eur J Cardiol 1975; 3:27.

JAMES TN. Morphology of the human atrioventricular node, with remarks pertinent to its
electrophysiology. Am Heart J 1961; 62:756.

Hamdan MH, Kalman JM, Lesh MD, et al. Narrow complex tachycardia with VA block: diagnostic and
therapeutic implications. Pacing Clin Electrophysiol 1998; 21:1196.

Morady F, Scheinman MM, Gonzalez R, Hess D. His-ventricular dissociation in a patient with

reciprocating tachycardia and a nodoventricular bypass tract. Circulation 1981; 64:839.

Wu DL, Yeh SJ, Yamamoto T, et al. Participation of a concealed nodoventricular fiber in the genesis of
paroxysmal tachycardias. Am Heart J 1990; 119:583.

Gillette PC, Garson A Jr, Cooley DA, McNamara DG. Prolonged and decremental antegrade conduction
properties in right anterior accessory connections: Wide QRS antidromic tachycardia of left bundle
branch block pattern without Wolff-Parkinson-White configuration in sinus rhythm. Am Heart J 1982;
103:66.

Klein GJ, Guiraudon GM, Kerr CR, et al. “Nodoventricular” accessory pathway: evidence for a distinct
accessory atrioventricular pathway with atrioventricular node-like properties. J Am Coll Cardiol 1988;
11:1035.

Becker AE, Anderson RH, Durrer D, Wellens HJ. The anatomical substrates of wolff-parkinson-white
syndrome. A clinicopathologic correlation in seven patients. Circulation 1978; 57:870.

Klein LS, Hackett FK, Zipes DP, Miles WM. Radiofrequency catheter ablation of Mahaim fibers at the
tricuspid annulus. Circulation 1993; 87:738.

Jongbloed MR, Wijffels MC, Schalij MJ, et al. Development of the right ventricular inflow tract and
moderator band: a possible morphological and functional explanation for Mahaim tachycardia. Circ Res
2005; 96:776.

Haissaguerre M, Warin JF, Le Metayer P, et al. Catheter ablation of Mahaim fibers with preservation of
atrioventricular nodal conduction. Circulation 1990; 82:418.
Yang JD, Zhou GB, Sun Q, et al. Electrocardiographic and electrophysiologic differentiation between
atriofascicular, long atrioventricular, and short atrioventricular decrementally conducting accessory
pathways. Europace 2018; 20:1666.

Gandhavadi M, Sternick EB, Jackman WM, et al. Characterization of the distal insertion of atriofascicular
accessory pathways and mechanisms of QRS patterns in atriofascicular antidromic tachycardia. Heart
Rhythm 2013; 10:1385.

Sternick EB, Timmermans C, Rodriguez LM, Wellens HJ. Mahaim fiber: an atriofascicular or a long
atrioventricular pathway? Heart Rhythm 2004; 1:724.

Ellenbogen KA, Ramirez NM, Packer DL, et al. Accessory nodoventricular (Mahaim) fibers: a clinical
review. Pacing Clin Electrophysiol 1986; 9:868.

Walsh EP. Ebstein’s Anomaly of the Tricuspid Valve: A Natural Laboratory for Re-Entrant Tachycardias.
JACC Clin Electrophysiol 2018; 4:1271.

Gallagher JJ, Smith WM, Kasell JH, et al. Role of Mahaim fibers in cardiac arrhythmias in man. Circulation
1981; 64:176.

Bardy GH, German LD, Packer DL, et al. Mechanism of tachycardia using a nodofascicular Mahaim fiber.
Am J Cardiol 1984; 54:1140.

Bardy GH, Fedor JM, German LD, et al. Surface electrocardiographic clues suggesting presence of a
nodofascicular Mahaim fiber. J Am Coll Cardiol 1984; 3:1161.

Sung RJ, Styperek JL. Electrophysiologic identification of dual atrioventricular nodal pathway conduction
in patients with reciprocating tachycardia using anomalous bypass tracts. Circulation 1979; 60:1464.

Abbott JA, Scheinman MM, Morady F, et al. Coexistent Mahaim and Kent accessory connections:
diagnostic and therapeutic implications. J Am Coll Cardiol 1987; 10:364.

Arias MA, Pachón M, Martín-Sierra C. Spontaneous Wide QRS Complex Rhythm in a Patient With Wide
QRS Complex Tachycardia. Circulation 2020; 141:1498.

Venier S, Khairy P, Thibault B, Rivard L. Ablation of a symptomatic spontaneous automatic focus arising
from an atriofascicular fiber. HeartRhythm Case Rep 2016; 2:379.

Strohmer B, Schernthaner C, Hwang C. Spontaneous automaticity arising from a successfully ablated

Mahaim fiber. J Interv Card Electrophysiol 2007; 20:25.

Liao Z, Ma J, Hu J, et al. New observation of electrocardiogram during sinus rhythm on the atriofascicular
and decremental atrioventricular pathways/clinical perspective: [corrected] terminal QRS [corrected]
complex slurring or notching. Circ Arrhythm Electrophysiol 2011; 4:897.

Sternick EB, Lokhandwala Y, Bohora S, et al. Is the 12-lead electrocardiogram during antidromic circus
movement tachycardia helpful in predicting the ablation site in atriofascicular pathways? Europace
2014; 16:1610.
McClelland JH, Wang X, Beckman KJ, et al. Radiofrequency catheter ablation of right atriofascicular
(Mahaim) accessory pathways guided by accessory pathway activation potentials. Circulation 1994;
89:2655.

Tchou P, Lehmann MH, Jazayeri M, Akhtar M. Atriofascicular connection or a nodoventricular Mahaim

fiber? Electrophysiologic elucidation of the pathway and associated reentrant circuit. Circulation 1988;
77:837.

Haïssaguerre M, Cauchemez B, Marcus F, et al. Characteristics of the ventricular insertion sites of

accessory pathways with anterograde decremental conduction properties. Circulation 1995; 91:1077.

Sherwin ED, Walsh EP, Abrams DJ. Variable QRS morphologies in Ebstein’s anomaly: what is the
mechanism? Heart Rhythm 2013; 10:933.

Okishige K, Strickberger SA, Walsh EP. Catheter ablation of the atrial origin of a decrementally
conducting atriofascicular accessory pathway by radiofrequency current. J Cardiovasc Electrophysiol
1991; 2:465.

Heald SC, Davies DW, Ward DE, et al. Radiofrequency catheter ablation of Mahaim tachycardia by
targeting Mahaim potentials at the tricuspid annulus. Br Heart J 1995; 73:250.

Brugada J, Martínez-Sánchez J, Kuzmicic B, et al. Radiofrequency catheter ablation of atriofascicular

accessory pathways guided by discrete electrical potentials recorded at the tricuspid annulus. Pacing
Clin Electrophysiol 1995; 18:1388.

Cardona-Guarache R, Han FT, Nguyen DT, et al. Ablation of Supraventricular Tachycardias From
Concealed Left-Sided Nodoventricular and Nodofascicular Accessory Pathways. Circ Arrhythm
Electrophysiol 2020; 13:e007853.

Jackman WM. Recording the Accessory His Bundle Potential from a Right Atriofascicular Accessory
Pathway. Card Electrophysiol Clin 2016; 8:765.

Mönnig G, Wasmer K, Milberg P, et al. Predictors of long-term success after catheter ablation of
atriofascicular accessory pathways. Heart Rhythm 2012; 9:704.

Ellenbogen KA, Rogers R, Old W. Pharmacological characterization of conduction over a Mahaim fiber:
evidence for adenosine sensitive conduction. Pacing Clin Electrophysiol 1989; 12:1396.

Strasberg B, Coelho A, Palileo E, et al. Pharmacological observations in patients with nodoventricular

pathways. Br Heart J 1984; 51:84.

Topic 1001 Version 18.0

© 2020 UpToDate, Inc. All rights reserved.